Healthy free cash flow has enabled Johnson & Johnson (JNJ) to increase its dividend over the past half century, notes Lee Bohl. He and Damien Conover discuss takeaways from JNJ earnings. JNJ's 1Q worldwide pharmaceutical sales came in at $13.41B and its 1Q revenue came in at $24.75B versus an estimated $23.57B. They also go over other stocks to keep on your radar. Tune in to find out more about the stock market today.
Trading 360
18 Apr 2023
SHARE
Market On Close
23 Jan 2024
Morning Trade Live
26 Jan 2024
Morning Trade Live
08 Mar 2024
The Watch List
30 Jan 2024
Morning Trade Live
28 Mar 2024
Market On Close
14 Feb 2024